Herb Cross

Herb Cross

Chief Financial Officer and Corporate SecretaryatJasper Therapeutics· In proxies 2023–2025

Pay in FY2025+1% from the year before · Jasper Therapeutics stock -91.4% the same year

Herb Cross was paid $1.3M in FY2025 (Dec), up 1%. Jasper Therapeutics stock fell 91.4% that year.

Pay$100 in the stock at the end of FY22 → $38
Pay is from the Summary Compensation Table of each Jasper Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Jasper TherapeuticsPublic company · 3 yr
    • Chief Financial Officer and Corporate Secretary2023 – Present · 3 yrStock in role -91%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?